Quick Facts: Allergic Bronchopulmonary Aspergillosis (ABPA)
ABPA is an allergic condition, not an invasive infection
Most often occurs in people with asthma or cystic fibrosis
Can lead to bronchiectasis (permanent airway damage)
Early diagnosis is critical to prevent long-term complications
What Is Allergic Bronchopulmonary Aspergillosis (ABPA)?
Allergic Bronchopulmonary Aspergillosis (ABPA) is a chronic inflammatory lung condition caused by an exaggerated immune response to the fungus Aspergillus fumigatus. This fungus is commonly found in the environment and can be present in the airways without causing an invasive infection.
In ABPA, the immune system overreacts to this presence, leading to airway inflammation and mucus buildup, which may lead to progressive lung damage if not appropriately managed.
Symptoms of Allergic Bronchopulmonary Aspergillosis (ABPA)
Common Symptoms
- Persistent or worsening asthma symptoms
- Chronic cough with brown or black mucus plugs
- Shortness of breath
- Wheezing not responding to usual treatment
- Fatigue or general malaise
- Low-grade fever
- Chest discomfort
- Occasional coughing up blood (hemoptysis)
- Unintentional weight loss (advanced cases)
Why Early Diagnosis Matters
ABPA can be difficult to recognize because its symptoms often resemble asthma that is not responding well to treatment. Many patients are treated for repeated asthma flare-ups before the underlying cause is identified.
Because of this, the condition can go unrecognized for extended periods. Early diagnosis allows for targeted treatment that can reduce inflammation, prevent flare-ups, and help protect long-term lung function.
ABPA vs Asthma
While ABPA occurs in people with asthma, it involves an allergic reaction to a fungus that can cause excess mucus buildup, airway blockage, and progressive lung damage beyond what is typically seen in asthma alone.
ABPA Timeline Insight
ABPA often develops gradually over months to years, with periods of flare-ups and remission. If not appropriately managed, repeated inflammation can lead to progressive lung damage.
Types and Stages of ABPA
ABPA is a single condition that progresses through clinical stages rather than separate diseases.
Clinical Stages of ABPA
Stage I: Acute Exacerbation
Sudden worsening symptoms, high IgE, new infiltrates
Stage II: Remission
Symptom improvement, lowered IgE, stable imaging
Stage III: Recurrence
Rise in IgE and symptom relapse after remission
Stage IV: Steroid-Dependent ABPA
Symptoms recur without corticosteroids
Stage V: Fibrotic (End-Stage) Disease
Irreversible bronchiectasis, fibrosis, chronic obstruction
ABPA Variants Based on Underlying Condition
- ABPA in Asthma
- CF-ABPA (ABPA in Cystic Fibrosis)
How ABPA Is Diagnosed
Clinical Evaluation
- History of asthma or cystic fibrosis
- Persistent or worsening respiratory symptoms
Laboratory Testing
- Elevated total IgE levels (often above 1000 IU/mL, though thresholds may vary)
- Positive Aspergillus-specific IgE and IgG
- Positive skin testing
- Elevated eosinophil count
Imaging Studies
- Chest X-ray: may show temporary lung changes
- High-resolution CT (HRCT): key diagnostic tool
- Central bronchiectasis
- Mucus plugging (including high-density mucus)
Diagnostic Approach
Diagnosis is based on a combination of:
- Clinical history
- Laboratory findings
- Imaging results
This helps distinguish ABPA from severe asthma or cystic fibrosis exacerbations.
Treatment Options for ABPA
Corticosteroids (First-Line Treatment)
- Reduce airway inflammation
- Typically used with a tapering schedule
- Require monitoring for long-term side effects
Antifungal Medications
- Examples: itraconazole, voriconazole
- May help reduce fungal burden and decrease reliance on long-term corticosteroids
- Require monitoring for liver function and drug interactions
Bronchodilators
- Used for symptom relief
- Include rescue and maintenance inhalers
Mucolytics (Especially in CF-ABPA)
- Dornase alfa for mucus clearance
Biologic Therapies
- Omalizumab (anti-IgE)
- Biologic therapies (such as anti-IgE and anti–IL-5/IL-4 pathway treatments) may be considered in selected patients
Airway Clearance Techniques
- Chest physiotherapy
- Oscillatory devices
- Postural drainage
Long-Term Monitoring
- Regular IgE level tracking
- Pulmonary function testing
- Imaging when clinically indicated
Why IgE Monitoring Matters
Tracking IgE levels over time helps physicians monitor disease activity and detect early signs of relapse, often before symptoms worsen.
Which Specialists Treat ABPA?
- Pulmonologist: Primary diagnosis and management
- Allergist/Immunologist: Allergy testing and biologic therapy
- Cystic Fibrosis Specialist: For CF-related cases
- Radiologist: Imaging interpretation
When to See a Specialist for ABPA
You should seek medical evaluation if you experience:
- Asthma symptoms worsening despite treatment
- Recurrent flare-ups or severe asthma attacks
- Persistent cough with thick, dark, or mucus plugs
- Declining lung function or increasing shortness of breath
- Symptoms that continue despite standard inhaler use
- Suspected relapse or worsening condition
FAQs About ABPA
ABPA is an allergic reaction to Aspergillus, not a contagious infection.
ABPA is a chronic condition but can be effectively managed to reduce symptoms and prevent complications.
No, it cannot be spread from person to person.
If untreated, it can lead to permanent lung damage and bronchiectasis.
With proper treatment and monitoring, many patients achieve stable control and reduced flare-ups.
Get Expert Care for ABPA
Persistent breathing symptoms or worsening asthma may be a sign of an underlying condition like ABPA. Early evaluation can help prevent long-term lung complications and improve symptom control.
At CLS Health, our specialists provide comprehensive, personalized care designed to provide clear answers and help you gain better control of your symptoms sooner.
Schedule your evaluation to receive:
✔ Comprehensive diagnostic testing to confirm the cause
✔ A personalized treatment plan tailored to your condition
✔ Access to advanced therapies, including biologic treatments when appropriate
